These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

245 related articles for article (PubMed ID: 3927286)

  • 41. Crystallization of single-chain Fv proteins.
    Essig NZ; Wood JF; Howard AJ; Raag R; Whitlow M
    J Mol Biol; 1993 Dec; 234(3):897-901. PubMed ID: 8254684
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Multimerization behaviour of single chain Fv variants for the tumour-binding antibody B72.3.
    Desplancq D; King DJ; Lawson AD; Mountain A
    Protein Eng; 1994 Aug; 7(8):1027-33. PubMed ID: 7809029
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The de novo design of an antibody combining site. Crystallographic analysis of the VL domain confirms the structural model.
    Essen LO; Skerra A
    J Mol Biol; 1994 Apr; 238(2):226-44. PubMed ID: 8158652
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The 2.0-A resolution crystal structure of a trimeric antibody fragment with noncognate VH-VL domain pairs shows a rearrangement of VH CDR3.
    Pei XY; Holliger P; Murzin AG; Williams RL
    Proc Natl Acad Sci U S A; 1997 Sep; 94(18):9637-42. PubMed ID: 9275175
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Antigen-binding specificities of antibodies are primarily determined by seven residues of VH.
    Ohno S; Mori N; Matsunaga T
    Proc Natl Acad Sci U S A; 1985 May; 82(9):2945-9. PubMed ID: 3921967
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Systematic classification of CDR-L3 in antibodies: implications of the light chain subtypes and the VL-VH interface.
    Kuroda D; Shirai H; Kobori M; Nakamura H
    Proteins; 2009 Apr; 75(1):139-46. PubMed ID: 18798566
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Molecular anatomy of the antibody binding site.
    Novotný J; Bruccoleri R; Newell J; Murphy D; Haber E; Karplus M
    J Biol Chem; 1983 Dec; 258(23):14433-7. PubMed ID: 6643494
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Structural base of the interaction of a monoclonal antibody against p24 of HIV-1 with its peptide epitope.
    Höhne WE; Küttner G; Kiessig S; Hausdorf G; Grunow R; Winkler K; Wessner H; Giessmann E; Stigler R; Schneider-Mergener J
    Mol Immunol; 1993 Sep; 30(13):1213-21. PubMed ID: 7692237
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The structural basis of antigen-antibody recognition.
    Mariuzza RA; Phillips SE; Poljak RJ
    Annu Rev Biophys Biophys Chem; 1987; 16():139-59. PubMed ID: 2439094
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Constant heavy-chain (CH1) and L-chain dependence of rabbit VH allotype determinants demonstrated by polyethylene glycol precipitation radioimmunoassays.
    Jensenius JC; Johnstone AP; Crone M; Andersen I
    Mol Immunol; 1982 Apr; 19(4):571-7. PubMed ID: 6178015
    [No Abstract]   [Full Text] [Related]  

  • 51. Analysis and prediction of VH/VL packing in antibodies.
    Abhinandan KR; Martin AC
    Protein Eng Des Sel; 2010 Sep; 23(9):689-97. PubMed ID: 20591902
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Noncovalent association of heavy and light chains of human immunoglobulins. III. Specific interactions between VH and VL.
    Horne C; Klein M; Polidoulis I; Dorrington KJ
    J Immunol; 1982 Aug; 129(2):660-4. PubMed ID: 6806377
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Solution structure of an isolated antibody VL domain.
    Constantine KL; Friedrichs MS; Metzler WJ; Wittekind M; Hensley P; Mueller L
    J Mol Biol; 1994 Feb; 236(1):310-27. PubMed ID: 8107112
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Germline-Dependent Antibody Paratope States and Pairing Specific V
    Fernández-Quintero ML; Kroell KB; Bacher LM; Loeffler JR; Quoika PK; Georges G; Bujotzek A; Kettenberger H; Liedl KR
    Front Immunol; 2021; 12():675655. PubMed ID: 34447370
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The critical role of arginine residues in the binding of human monoclonal antibodies to cardiolipin.
    Giles I; Lambrianides N; Latchman D; Chen P; Chukwuocha R; Isenberg D; Rahman A
    Arthritis Res Ther; 2005; 7(1):R47-56. PubMed ID: 15642142
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Variable heavy-variable light domain and Fab-arm CrossMabs with charged residue exchanges to enforce correct light chain assembly.
    Regula JT; Imhof-Jung S; Mølhøj M; Benz J; Ehler A; Bujotzek A; Schaefer W; Klein C
    Protein Eng Des Sel; 2018 Jul; 31(7-8):289-299. PubMed ID: 30169707
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Building novel binding ligands to B7.1 and B7.2 based on human antibody single variable light chain domains.
    van den Beucken T; van Neer N; Sablon E; Desmet J; Celis L; Hoogenboom HR; Hufton SE
    J Mol Biol; 2001 Jul; 310(3):591-601. PubMed ID: 11439026
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Single domain antibodies: comparison of camel VH and camelised human VH domains.
    Riechmann L; Muyldermans S
    J Immunol Methods; 1999 Dec; 231(1-2):25-38. PubMed ID: 10648925
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Alternative mechanism of protein A-immunoglobulin interaction the VH-associated reactivity of a monoclonal human IgM.
    Vidal MA; Conde FP
    J Immunol; 1985 Aug; 135(2):1232-8. PubMed ID: 3925002
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Coevolution of immunoglobulin heavy- and light-chain variable-region gene families.
    Sitnikova T; Su C
    Mol Biol Evol; 1998 Jun; 15(6):617-25. PubMed ID: 9615443
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.